CR20110373A - Preparación de liberación controlada (divisional solicitud n° 10284) - Google Patents
Preparación de liberación controlada (divisional solicitud n° 10284)Info
- Publication number
- CR20110373A CR20110373A CR20110373A CR20110373A CR20110373A CR 20110373 A CR20110373 A CR 20110373A CR 20110373 A CR20110373 A CR 20110373A CR 20110373 A CR20110373 A CR 20110373A CR 20110373 A CR20110373 A CR 20110373A
- Authority
- CR
- Costa Rica
- Prior art keywords
- active ingredient
- controlled release
- preparation
- controlled
- granule
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se provee una preparación de liberación controlada en la cual la liberación del ingrediente activo está controlada, la cual libera un ingrediente activo durante un período prolongado de tiempo permaneciendo o migrando lentamente por el tracto gastrointestinal, meidante el encapsulamiento de una tableta, gránulo o gránulo fino en los cuales la liberación del ingrediente activo está controlada y un prolímero formador de geles. Dicha tableta, gránulo o gránulo fino presenta una capa de recubrimiento de liberación controlada formada sobre una partícula central que tiene un ingrediente activo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002301876 | 2002-10-16 | ||
JP2003066336 | 2003-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20110373A true CR20110373A (es) | 2011-08-24 |
Family
ID=32109465
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10284A CR10284A (es) | 2002-10-16 | 2008-09-12 | Preparacion de liberacion controlada.(divisional exp. 7761) |
CR20110373A CR20110373A (es) | 2002-10-16 | 2011-06-29 | Preparación de liberación controlada (divisional solicitud n° 10284) |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10284A CR10284A (es) | 2002-10-16 | 2008-09-12 | Preparacion de liberacion controlada.(divisional exp. 7761) |
Country Status (28)
Country | Link |
---|---|
US (7) | US7790755B2 (es) |
EP (3) | EP2283827B1 (es) |
JP (2) | JP5330967B2 (es) |
KR (3) | KR20100132082A (es) |
CN (1) | CN101884629B (es) |
AR (1) | AR041562A1 (es) |
AU (2) | AU2003272098B2 (es) |
BR (2) | BRPI0315142B8 (es) |
CA (2) | CA2499574C (es) |
CR (2) | CR10284A (es) |
CY (1) | CY1114599T1 (es) |
DK (1) | DK1553929T3 (es) |
ES (1) | ES2410812T5 (es) |
HK (1) | HK1080378A1 (es) |
IL (1) | IL167447A (es) |
MA (1) | MA27456A1 (es) |
MX (2) | MXPA05003902A (es) |
MY (2) | MY148805A (es) |
NO (2) | NO342002B1 (es) |
NZ (2) | NZ539353A (es) |
OA (1) | OA13143A (es) |
PE (3) | PE20090076A1 (es) |
PL (2) | PL219122B1 (es) |
PT (1) | PT1553929E (es) |
SG (1) | SG164281A1 (es) |
SI (1) | SI1553929T1 (es) |
TW (2) | TWI378794B (es) |
WO (1) | WO2004035020A2 (es) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
FR2830447B1 (fr) * | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques |
WO2003084518A2 (fr) | 2002-04-09 | 2003-10-16 | Flamel Technologies | Suspension orale de microcapsules de principes actifs |
WO2004080439A1 (ja) | 2003-03-12 | 2004-09-23 | Takeda Pharmaceutical Company Limited | 高濃度に活性成分を球形核に付着させた医薬組成物 |
CA2519208A1 (en) | 2003-03-17 | 2004-09-30 | Takeda Pharmaceutical Company Limited | Controlled release composition |
TW200606163A (en) | 2004-04-22 | 2006-02-16 | Eisai Co Ltd | Imidazopyridine compound |
AU2005264864B2 (en) | 2004-06-16 | 2011-08-11 | Takeda Pharmaceutical Company Limited | Multiple PPI dosage form |
US8871273B2 (en) | 2005-02-25 | 2014-10-28 | Takeda Pharmaceutical Company Limited | Method for producing granules |
WO2006093353A1 (ja) * | 2005-03-03 | 2006-09-08 | Takeda Pharmaceutical Company Limited | 放出制御組成物 |
US20070015782A1 (en) | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
WO2007074108A1 (en) * | 2005-12-28 | 2007-07-05 | Basf Se | Process for production of a water-absorbing material |
EP2012756A4 (en) * | 2006-04-20 | 2013-01-23 | Inventia Healthcare Private Ltd | MULTI-UNIT COMPOSITIONS |
US20080181932A1 (en) * | 2007-01-30 | 2008-07-31 | Drugtech Corporation | Compositions for oral delivery of pharmaceuticals |
US8679541B2 (en) * | 2007-03-14 | 2014-03-25 | Particle Dynamics International, Llc | Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals |
CN101896171B (zh) * | 2007-05-08 | 2012-05-23 | 陶氏环球技术公司 | 水分散性聚合物组合物 |
CN104069088A (zh) * | 2007-10-12 | 2014-10-01 | 武田制药北美公司 | 与食物摄入无关的治疗胃肠病症的方法 |
EP2573082A1 (en) | 2007-12-31 | 2013-03-27 | Takeda Pharmaceutical Company Limited | Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
TWI441658B (zh) | 2008-03-11 | 2014-06-21 | Takeda Pharmaceutical | 口腔崩解固體製劑 |
TWI519322B (zh) * | 2008-04-15 | 2016-02-01 | 愛戴爾製藥股份有限公司 | 包含弱鹼性藥物及控制釋放劑型之組合物 |
FR2938432B1 (fr) * | 2008-11-14 | 2011-05-20 | Debregeas Et Associes Pharma | Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus |
CN105343885A (zh) * | 2009-11-20 | 2016-02-24 | 汉达医药有限责任公司 | 右兰索拉唑的口服配方 |
US20110189271A1 (en) * | 2010-02-02 | 2011-08-04 | Vishal Lad | Pharmaceutical formulations of acid-labile drugs |
TWI446916B (zh) | 2010-05-12 | 2014-08-01 | Spectrum Pharmaceuticals Inc | 鹼式碳酸鑭、碳酸氧鑭及其製備方法及用途 |
EP2570120B1 (en) * | 2010-06-08 | 2017-10-25 | Kobe Gakuin Educational Foundation | Coated particle and method for producing coated particle |
ES2669184T3 (es) | 2010-06-16 | 2018-05-24 | Takeda Pharmaceuticals U.S.A., Inc. | Nuevas formas de dosificación de liberación modificada de inhibidor de xantina oxidorreductasa o inhibidores de xantina oxidasa |
US20130216617A1 (en) | 2010-06-29 | 2013-08-22 | Cadila Healthcare Limited | Pharmaceutical compositions of (r)-lansoprazole |
US20120201886A1 (en) * | 2010-07-30 | 2012-08-09 | Micro Labs Limited | Coated Extended Release Pharmaceutical Compositions Containing Paliperidone |
US20120164233A1 (en) | 2010-07-30 | 2012-06-28 | Ranbaxy Laboratories Limited | Pulsatile release pharmaceutical formulation of dexlansoprazole |
UA112855C2 (uk) * | 2010-12-29 | 2016-11-10 | Др. Редді'С Лабораторіс Лтд. | Композиції бензімідазолів з модифікованим вивільненням |
WO2012103411A2 (en) | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
JP6025755B2 (ja) | 2011-02-11 | 2016-11-16 | ズィーエックス ファーマ,エルエルシー | 多粒子l−メントール製剤及びその関連する方法 |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
WO2012111024A1 (en) | 2011-02-18 | 2012-08-23 | Suven Nishtaa Pharma Pvt Ltd | Pharmaceutical compositions of dexlansoprazole |
WO2013058409A1 (en) | 2011-10-21 | 2013-04-25 | Takeda Pharmaceutical Company Limited | Sustained-release preparation |
US20130209592A1 (en) * | 2012-02-13 | 2013-08-15 | Steven C. Denstman | Plant Extract Based Compositions and Methods For Treating Chronic Wounds |
US20140330192A1 (en) * | 2012-02-13 | 2014-11-06 | The Ex Plant Company | Dressing for application to a wound or burn |
WO2014175852A1 (en) | 2013-04-23 | 2014-10-30 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
KR20160081322A (ko) | 2014-12-31 | 2016-07-08 | 삼아제약 주식회사 | 양성자 펌프 억제제를 유효성분으로 포함하며 방출이 제어된 약제학적 조성물 |
KR101907116B1 (ko) * | 2016-07-25 | 2018-10-11 | 한미약품 주식회사 | 에스오메프라졸, 또는 약학적으로 허용 가능한 그의 염을 포함하는, pH-의존성 약물 방출 특성이 개선된 제형 |
CN107648231B (zh) * | 2016-07-25 | 2021-07-16 | 江苏豪森药业集团有限公司 | 右兰索拉唑药物制剂 |
KR101877350B1 (ko) * | 2016-10-28 | 2018-08-09 | 한미약품 주식회사 | 에스오메프라졸 함유 복합 캡슐제 및 그 제조방법 |
KR20200097564A (ko) | 2019-02-08 | 2020-08-19 | 주식회사유한양행 | 덱스란소프라졸 또는 이의 약학적으로 허용 가능한 염을 함유하는 안정한 경구투여용 약학 제제 |
CN111909044A (zh) * | 2019-05-09 | 2020-11-10 | 南京爱德程医药科技有限公司 | 2-(烷基氨基)乙基苯甲酸酯类化合物的合成方法 |
CA3139155A1 (en) * | 2019-05-31 | 2020-12-03 | Denali Therapeutics Inc. | Modified release formulation of a pyrimidinylamino-pyrazole compound, and methods of treatment |
US11839622B1 (en) | 2020-01-15 | 2023-12-12 | Randall Lewarchik | Consumable nutraceutical composition |
KR102471545B1 (ko) | 2020-11-20 | 2022-11-29 | 서울대학교 산학협력단 | 덱스란소프라졸을 유효성분으로 포함하는 pH 의존성 타블렛-인-캡슐 복합제제 및 이의 제조방법 |
KR20230162001A (ko) * | 2021-03-11 | 2023-11-28 | 인 더 보울 애니멀 헬스, 인크. | 갯과에서 진드기 감염을 방제하기 위한 경구용 갯과 사료 및 방법 |
EP4304356A1 (en) * | 2021-03-11 | 2024-01-17 | In the Bowl Animal Health, Inc. | Oral canine feed and methods for controlling flea infestations in a canine |
KR20240014209A (ko) | 2022-07-25 | 2024-02-01 | 주식회사 와이에스생명과학 | 덱스란소프라졸 함유 정제 |
EP4356904A1 (en) * | 2022-10-19 | 2024-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A capsule comprising lansoprazole |
Family Cites Families (121)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE416649B (sv) | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
US4649043A (en) * | 1982-03-22 | 1987-03-10 | Alza Corporation | Drug delivery system for delivering a plurality of tiny pills in the gastrointestinal tract |
ZA854287B (en) | 1984-06-16 | 1986-02-26 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridines,process for their preparation,their use and medicaments containing them |
JPS6150978A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
KR890000387B1 (ko) | 1984-09-24 | 1989-03-16 | 디 엎존 캄파니 | 2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법 |
IL76839A (en) | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
GB8507779D0 (en) * | 1985-03-26 | 1985-05-01 | Fujisawa Pharmaceutical Co | Drug carrier |
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
SE8505112D0 (sv) | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
CA1327010C (en) * | 1986-02-13 | 1994-02-15 | Tadashi Makino | Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
JPS62277322A (ja) | 1986-02-13 | 1987-12-02 | Takeda Chem Ind Ltd | 安定化された腸溶性抗潰瘍固形組成物 |
US4794001A (en) * | 1986-03-04 | 1988-12-27 | American Home Products Corporation | Formulations providing three distinct releases |
JPH07121859B2 (ja) | 1986-03-18 | 1995-12-25 | 第一製薬株式会社 | 徐放性カプセル剤 |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
JPH0643426B2 (ja) | 1986-07-25 | 1994-06-08 | 東京田辺製薬株式会社 | イミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
JPH0674272B2 (ja) | 1986-11-13 | 1994-09-21 | エーザイ株式会社 | ピリジン誘導体及びそれを含有する潰瘍治療剤 |
US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
JPH0832625B2 (ja) | 1987-01-29 | 1996-03-29 | 武田薬品工業株式会社 | 有核顆粒およびその製造法 |
JP2549119B2 (ja) | 1987-05-30 | 1996-10-30 | 三省製薬株式会社 | 外用剤 |
JP2602518B2 (ja) * | 1988-01-27 | 1997-04-23 | エーザイ株式会社 | 被覆された胃酸分泌抑制剤含有組成物 |
DE3822095A1 (de) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | Neue arzneimittelformulierung sowie verfahren zu deren herstellung |
US4980172A (en) * | 1989-05-12 | 1990-12-25 | Fey Michael S | Anti-smoking oral composition |
FR2655266B1 (fr) | 1989-12-05 | 1992-04-03 | Smith Kline French Lab | Compositions pharmaceutiques a base de cimetidine. |
US4965269A (en) | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
US5229131A (en) * | 1990-02-05 | 1993-07-20 | University Of Michigan | Pulsatile drug delivery system |
US5264223A (en) * | 1990-03-29 | 1993-11-23 | Japan Elanco Company, Ltd. | Hard capsule for pharmaceutical drugs and method for producing the same |
US5286497A (en) * | 1991-05-20 | 1994-02-15 | Carderm Capital L.P. | Diltiazem formulation |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
DE69222006T2 (de) | 1991-10-30 | 1998-01-22 | Glaxo Group Ltd | Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten |
US5229135A (en) * | 1991-11-22 | 1993-07-20 | Prographarm Laboratories | Sustained release diltiazem formulation |
AU682827B2 (en) | 1992-09-18 | 1997-10-23 | Astellas Pharma Inc. | Sustained-release hydrogel preparation |
US5686105A (en) | 1993-10-19 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
US5651983A (en) * | 1993-02-26 | 1997-07-29 | The Procter & Gamble Company | Bisacodyl dosage form for colonic delivery |
US5914132A (en) * | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
US5656290A (en) | 1993-02-26 | 1997-08-12 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
JPH072650A (ja) * | 1993-06-18 | 1995-01-06 | Tanabe Seiyaku Co Ltd | 放出部位制御型製剤 |
SE9302395D0 (sv) | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
WO1995030422A1 (en) * | 1994-05-06 | 1995-11-16 | Pfizer Inc. | Controlled-release dosage forms of azithromycin |
SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
ES2100142T3 (es) * | 1994-07-08 | 2002-03-01 | Astrazeneca Ab | Forma de dosificacion en tabletas i constituida por unidades multiples. |
GB2290965A (en) * | 1994-07-11 | 1996-01-17 | Therapicon Srl | Multiple layer capsules for drugs |
SE504459C2 (sv) | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
HRP960232A2 (en) | 1995-07-03 | 1998-02-28 | Astra Ab | A process for the optical purification of compounds |
US5945124A (en) | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
SG80553A1 (en) * | 1995-07-20 | 2001-05-22 | Tanabe Seiyaku Co | Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract |
PL186605B1 (pl) * | 1995-09-21 | 2004-01-30 | Pharma Pass Llc | Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol |
US5567144A (en) * | 1995-10-05 | 1996-10-22 | Desa International Inc. | Hot surface ignition controller for fuel oil burner |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US5840737A (en) * | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
SE9600072D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
SE9600070D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
JPH09188617A (ja) * | 1996-01-08 | 1997-07-22 | Pola Chem Ind Inc | 徐放性医薬組成物 |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
HU226595B1 (en) | 1996-03-08 | 2009-04-28 | Nycomed Danmark As | Modified release multiple-units dosage composition |
US6156340A (en) * | 1996-03-29 | 2000-12-05 | Duquesne University Of The Holy Ghost | Orally administrable time release drug containing products |
SE9602442D0 (sv) * | 1996-06-20 | 1996-06-20 | Astra Ab | Administration of pharmaceuticals |
US5972389A (en) * | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
GB9620709D0 (en) * | 1996-10-04 | 1996-11-20 | Danbiosyst Uk | Colonic delivery of weak acid drugs |
JP3828648B2 (ja) | 1996-11-14 | 2006-10-04 | 武田薬品工業株式会社 | 2−(2−ピリジルメチルスルフィニル)ベンズイミダゾール系化合物の結晶およびその製造法 |
TW385306B (en) | 1996-11-14 | 2000-03-21 | Takeda Chemical Industries Ltd | Method for producing crystals of benzimidazole derivatives |
WO1998029095A2 (en) | 1997-01-03 | 1998-07-09 | Elan Corporation, Plc | Sustained release cisapride mini-tablet formulation |
US6162463A (en) * | 1997-05-01 | 2000-12-19 | Dov Pharmaceutical Inc | Extended release formulation of diltiazem hydrochloride |
KR20010012402A (ko) * | 1997-05-09 | 2001-02-15 | 세이지 파마슈티칼스, 인크. | 안정한 약제학적 경구 투여형 |
DE19732903A1 (de) * | 1997-07-30 | 1999-02-04 | Falk Pharma Gmbh | Pellet-Formulierung zur Behandlung des Intestinaltraktes |
US5885616A (en) * | 1997-08-18 | 1999-03-23 | Impax Pharmaceuticals, Inc. | Sustained release drug delivery system suitable for oral administration |
DE19742711C1 (de) * | 1997-09-26 | 1999-05-20 | Intec Bielenberg Gmbh & Co Kg | Vorrichtung zum Aufbringen von Klebepunkten auf ein Substrat |
KR100387245B1 (ko) * | 1997-10-17 | 2003-08-19 | 일양약품주식회사 | 유산균의안정화를위한미세장용성코팅과립 |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
WO1999029303A1 (en) | 1997-12-12 | 1999-06-17 | Samyang Corporation | Biodegradable mixed polymeric micelles for gene delivery |
SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
SE9704870D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
DE19801811B4 (de) | 1998-01-19 | 2004-12-23 | Stada Arzneimittel Ag | Pharmazeutische Zubereitung zur oralen Verabreichung |
EP1056456A4 (en) | 1998-01-30 | 2006-10-25 | Sepracor Inc | R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR |
DK173431B1 (da) * | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
US5945123A (en) | 1998-04-02 | 1999-08-31 | K-V Pharmaceutical Company | Maximizing effectiveness of substances used to improve health and well being |
US6372254B1 (en) * | 1998-04-02 | 2002-04-16 | Impax Pharmaceuticals Inc. | Press coated, pulsatile drug delivery system suitable for oral administration |
EP1067910B1 (en) * | 1998-04-03 | 2004-05-26 | Egalet A/S | Controlled release composition |
CN1141097C (zh) | 1998-04-20 | 2004-03-10 | 卫材株式会社 | 含有稳定化的苯并咪唑类化合物的组合物 |
DE19820529A1 (de) * | 1998-05-08 | 1999-11-11 | Lohmann Therapie Syst Lts | Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung |
EP1121103B1 (en) * | 1998-05-18 | 2006-12-20 | Takeda Pharmaceutical Company Limited | Orally disintegrable tablets comprising a benzimidazole |
ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
ES2347968T3 (es) | 1998-07-28 | 2010-11-26 | Takeda Pharmaceutical Company Limited | Preparacion solida que se disgrega rapidamente. |
IT1301947B1 (it) | 1998-07-28 | 2000-07-20 | Chiesi Farma Spa | Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa |
US6093734A (en) | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
SI1105105T1 (sl) | 1998-08-12 | 2006-08-31 | Altana Pharma Ag | Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole |
JP2000119181A (ja) | 1998-10-06 | 2000-04-25 | Kureha Chem Ind Co Ltd | エスクレチン及びその誘導体の放出制御経口製剤 |
PT1126826E (pt) * | 1998-11-02 | 2008-11-25 | Elan Pharma Int Ltd | Composição de metilfenidato de libertação modificada multiparticulada |
US6511678B2 (en) * | 1998-12-18 | 2003-01-28 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
TWI289557B (en) | 1999-06-17 | 2007-11-11 | Takeda Chemical Industries Ltd | A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole |
EP1064938A1 (en) | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
IL131508A (en) | 1999-08-19 | 2006-12-10 | David Cohen | Micronexulatory formulations and controlled dispersion of isoflavins from rich masses of sesame and other plants |
EP1206250A2 (en) | 1999-08-26 | 2002-05-22 | ELAN CORPORATION, Plc | Pharmaceutical formulations with different release times |
ES2168043B1 (es) | 1999-09-13 | 2003-04-01 | Esteve Labor Dr | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
CA2386277A1 (en) | 1999-10-01 | 2001-04-12 | Natco Pharma Limited | An improved pharmaceutical composition and a process for its preparation |
GB9923436D0 (en) | 1999-10-04 | 1999-12-08 | American Home Prod | Pharmaceutical compositions |
DK1280795T3 (da) | 1999-11-02 | 2005-07-18 | Basilea Pharmaceutica Ag | N-substituerede carbamoyloxyalkyl-azolium-derivater |
US6627223B2 (en) | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
IT1318376B1 (it) | 2000-03-07 | 2003-08-25 | Pharmatec Internat S R L | Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo. |
DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
AU2001247887A1 (en) | 2000-04-19 | 2001-11-07 | Eurand America Inc. | Dual mechanism timed release dosage forms for low dose drugs |
KR100775802B1 (ko) | 2000-04-28 | 2007-11-12 | 다케다 야쿠힌 고교 가부시키가이샤 | 광학 활성 술폭시드 유도체의 제조 방법 |
US6419954B1 (en) | 2000-05-19 | 2002-07-16 | Yamanouchi Pharmaceutical Co., Ltd. | Tablets and methods for modified release of hydrophilic and other active agents |
US6306435B1 (en) * | 2000-06-26 | 2001-10-23 | Yung Shin Pharmaceutical Industrial Co. Ltd. | Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same |
TWI232761B (en) * | 2000-07-01 | 2005-05-21 | Pharmaceutical Ind Tech & Dev | Capsule preparation for oral administration and the preparation method thereof |
IT1318625B1 (it) * | 2000-07-14 | 2003-08-27 | Roberto Valducci | Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente. |
CA2417311C (en) | 2000-08-04 | 2012-07-10 | Takeda Chemical Industries, Ltd. | Crystalline alkali metal salts of lansoprazole and their production and use |
US6500457B1 (en) | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
JP2004507487A (ja) | 2000-08-29 | 2004-03-11 | メファ・アクチェンゲゼルシャフト | 腸疾患治療薬 |
AU2001296908A1 (en) * | 2000-09-29 | 2002-04-08 | Geneva Pharmaceuticals, Inc. | Proton pump inhibitor formulation |
JP2002187890A (ja) | 2000-10-12 | 2002-07-05 | Takeda Chem Ind Ltd | ベンズイミダゾール化合物、その製造法およびその用途 |
CA2425363A1 (en) | 2000-10-12 | 2003-04-10 | Fumihiko Sato | Benzimidazole compounds, process for producing the same and use thereof |
AU2001211213A1 (en) | 2000-10-20 | 2002-04-29 | Galephar M/F | Stable oral formulation containing benzimidazole derivative |
SI20720A (sl) * | 2000-11-20 | 2002-06-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Nov farmacevtski pripravek v obliki celuloznih kapsul uporaben za derivate benzimidazola |
ES2298236T3 (es) * | 2001-01-31 | 2008-05-16 | Evonik Rohm Gmbh | Forma medicamentosa de particulas multiples, que contiene por lo menos dos formas de granulos, revestidas de manera diferente. |
ITMI20010220A1 (it) | 2001-02-05 | 2002-08-05 | Valpharma Sa | Formulazioni multiparticolate per somministrazione orale di sali di litio idonee per una somministrazione al giorno |
ATE381924T1 (de) * | 2001-09-21 | 2008-01-15 | Egalet As | Feste dispersionen mit kontrollierter freisetzung von carvedilol |
EP1437352A4 (en) | 2001-09-25 | 2004-12-08 | Takeda Chemical Industries Ltd | BENZYMIDAZOLE COMPOUND, PROCESS FOR PRODUCING AND USING THE SAME |
AU2003238896A1 (en) | 2002-06-07 | 2003-12-22 | Geneva Pharmaceuticals, Inc. | Stabilized pharmaceutical compositions containing benzimidazole compounds |
EP1589951B1 (en) | 2003-01-03 | 2017-08-09 | Supernus Pharmaceuticals, Inc. | Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics |
-
2003
- 2003-10-07 MY MYPI20033821A patent/MY148805A/en unknown
- 2003-10-09 TW TW100111514A patent/TWI378794B/zh not_active IP Right Cessation
- 2003-10-09 TW TW092128054A patent/TWI347202B/zh not_active IP Right Cessation
- 2003-10-09 AR ARP030103672A patent/AR041562A1/es not_active Application Discontinuation
- 2003-10-10 PE PE2008001635A patent/PE20090076A1/es not_active Application Discontinuation
- 2003-10-10 PE PE2011001026A patent/PE20110544A1/es not_active Application Discontinuation
- 2003-10-10 PE PE2003001034A patent/PE20050102A1/es active IP Right Grant
- 2003-10-15 CN CN2010101671537A patent/CN101884629B/zh not_active Expired - Lifetime
- 2003-10-15 PL PL376222A patent/PL219122B1/pl unknown
- 2003-10-15 KR KR1020107026652A patent/KR20100132082A/ko not_active Application Discontinuation
- 2003-10-15 EP EP10177696.1A patent/EP2283827B1/en not_active Expired - Lifetime
- 2003-10-15 CA CA2499574A patent/CA2499574C/en not_active Expired - Lifetime
- 2003-10-15 KR KR1020057006572A patent/KR101061750B1/ko active IP Right Review Request
- 2003-10-15 WO PCT/JP2003/013155 patent/WO2004035020A2/en active Application Filing
- 2003-10-15 CA CA2737851A patent/CA2737851C/en not_active Expired - Lifetime
- 2003-10-15 DK DK03754116.6T patent/DK1553929T3/da active
- 2003-10-15 OA OA1200500107A patent/OA13143A/en unknown
- 2003-10-15 KR KR1020127004477A patent/KR101401913B1/ko active IP Right Grant
- 2003-10-15 US US10/531,069 patent/US7790755B2/en active Active
- 2003-10-15 BR BRPI0315142A patent/BRPI0315142B8/pt active IP Right Grant
- 2003-10-15 PL PL389571A patent/PL218177B1/pl unknown
- 2003-10-15 PT PT37541166T patent/PT1553929E/pt unknown
- 2003-10-15 EP EP03754116.6A patent/EP1553929B2/en not_active Expired - Lifetime
- 2003-10-15 SI SI200332270T patent/SI1553929T1/sl unknown
- 2003-10-15 EP EP10177692.0A patent/EP2277510B1/en not_active Expired - Lifetime
- 2003-10-15 AU AU2003272098A patent/AU2003272098B2/en not_active Expired
- 2003-10-15 NZ NZ539353A patent/NZ539353A/en not_active IP Right Cessation
- 2003-10-15 BR BR122016030094A patent/BR122016030094B8/pt active IP Right Grant
- 2003-10-15 ES ES03754116.6T patent/ES2410812T5/es not_active Expired - Lifetime
- 2003-10-15 SG SG200702817-8A patent/SG164281A1/en unknown
- 2003-10-15 MX MXPA05003902A patent/MXPA05003902A/es active IP Right Grant
- 2003-10-15 NZ NZ552592A patent/NZ552592A/en not_active IP Right Cessation
- 2003-10-15 MX MX2011000852A patent/MX337937B/es unknown
-
2005
- 2005-03-15 IL IL167447A patent/IL167447A/en active IP Right Grant
- 2005-04-19 MA MA28229A patent/MA27456A1/fr unknown
- 2005-05-13 NO NO20052400A patent/NO342002B1/no not_active IP Right Cessation
-
2006
- 2006-01-11 HK HK06100444.6A patent/HK1080378A1/xx not_active IP Right Cessation
-
2008
- 2008-09-12 CR CR10284A patent/CR10284A/es unknown
- 2008-11-24 MY MYPI20084749A patent/MY169471A/en unknown
-
2009
- 2009-11-20 JP JP2009265244A patent/JP5330967B2/ja not_active Expired - Lifetime
- 2009-11-27 AU AU2009243408A patent/AU2009243408B2/en not_active Expired
-
2010
- 2010-07-08 US US12/832,683 patent/US8722084B2/en not_active Expired - Lifetime
- 2010-07-08 US US12/832,659 patent/US20100272798A1/en not_active Abandoned
- 2010-07-19 US US12/839,054 patent/US8784885B2/en not_active Expired - Lifetime
-
2011
- 2011-06-29 CR CR20110373A patent/CR20110373A/es unknown
-
2013
- 2013-03-25 JP JP2013062667A patent/JP5746722B2/ja not_active Expired - Lifetime
- 2013-06-21 CY CY20131100508T patent/CY1114599T1/el unknown
-
2014
- 2014-03-06 US US14/199,334 patent/US20140186449A1/en not_active Abandoned
- 2014-03-06 US US14/199,308 patent/US20140186448A1/en not_active Abandoned
-
2015
- 2015-12-28 US US14/981,191 patent/US20160128945A1/en not_active Abandoned
-
2018
- 2018-01-17 NO NO20180072A patent/NO343175B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20110373A (es) | Preparación de liberación controlada (divisional solicitud n° 10284) | |
BR0317682A (pt) | Composição farmacêutica de liberação modificada | |
ES2176209T3 (es) | Preparacion farmaceutica oral liberable en el tracto digestivo inferior. | |
HRP20041152B1 (en) | Pharmaceutical formulations | |
ATE513541T1 (de) | Pharmazeutische zusammensetzungen zur oralen verabreichung von calcitonin | |
ITMI20011337A0 (it) | Composizioni farmaceutiche orali a rilascio modificato del principio attivo | |
IL173078A0 (en) | Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form | |
DE60335557D1 (de) | Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum | |
BR0305777A (pt) | Composição, e, cápsulas | |
NO20016108L (no) | Kontrollert frigivelse og smaks maskerende orale farmasöytiske sammensetninger | |
PT1439829E (pt) | Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa | |
ATE428407T1 (de) | Oralen arzneiform mit oeffnungen in der äusseren hülle | |
CR7761A (es) | Preparacion de liberacion controlada | |
CO5011082A1 (es) | Formulacion medicamentosa con liberacion controlada de sus- tancia activa | |
CL2007003010A1 (es) | Forma de dosificacion oral que comprende un nucleo erosionable que contiene un principio activo de caracter basico debil, un recubrimiento erosionable en torno a dicho nucleo con una o mas abertura que atraviesn el recubrimiento y conectan al nucleo con el medio de uso; procedimiento de preparacion; y uso (divisional de 260-03). | |
ATE303137T1 (de) | Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit | |
AR028525A1 (es) | Sistema terapeutico transdermal para la administracion de lerisetron | |
NO20024363D0 (no) | Nye LHRH-antagonister, produksjon og anvendelse av disse som medikamant | |
ATE338567T1 (de) | Pharmazeutische zubereitungen, wirkstoffe enthaltend, die sich für unerlaubte verabreichung anbieten | |
UY26176A1 (es) | Formas polimorfas de un citrato de azobiciclo (2,2,2) octan- 3-amina y sus composiciones farmacéuticas. | |
ATE357220T1 (de) | Pharmazeutische zusammensetzung mit modifizierter freisetzung | |
ATE449598T1 (de) | Geschmacksmaskierte orale zubereitung von telithromycin | |
RU2001100069A (ru) | Антгельминтное средство | |
UY27017A1 (es) | Composiciones hidrolíticamente inestables | |
GT200100223A (es) | Composiciones hidroliticamente inestables. |